Maarten A. Ligtenberg
- Immunology top 5%
- Immunotherapy and Immune Responses 11
- Immune Cell Function and Interaction 5
- Phagocytosis and Immune Regulation 2
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 11
- CAR-T cell therapy research 9
- Cancer Cells and Metastasis 4
- Infectious Diseases top 10%
-
- Cancer Research and Treatments 3
-
- vaccines and immunoinformatics approaches 2
- Co-authors
- Rolf KiesslingÁlvaro LladserDimitrios MougiakakosKristina WittDaniel S. PeeperTobias RiëtMarkus ChmielewskiMadhura Mukhopadhyay
- Journals
- Nature Medicine (1 paper)Nature Communications (2 papers)The Journal of Immunology (1 paper)
- Partner nations
- NetherlandsSwedenUnited States
In The Last Decade
Maarten A. Ligtenberg
21 papers receiving 956 citations
Peers
Comparison fields: 5 of 72
- Immunology 436
- Oncology 470
- Infectious Diseases 145
- Virology 31
- Cancer Research 94
Countries citing papers authored by Maarten A. Ligtenberg
This map shows the geographic impact of Maarten A. Ligtenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten A. Ligtenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten A. Ligtenberg more than expected).
Fields of papers citing papers by Maarten A. Ligtenberg
This network shows the impact of papers produced by Maarten A. Ligtenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten A. Ligtenberg. The network helps show where Maarten A. Ligtenberg may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maarten A. Ligtenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 10 | |
| 2 | 2022 | 30 | |
| 3 | 2022 | 34 | |
| 4 | 2022 | 1 | |
| 5 | 2021 | 3 | |
| 6 | 2021 | 48 | |
| 7 | 2020 | 66 | |
| 8 | 2020 | 9 | |
| 9 | 2019 | 22 | |
| 10 | 2019 | 3 | |
| 11 | 2019 | 11 | |
| 12 | 2018 | 29 | |
| 13 | 2018 | 39 | |
| 14 | 2018 | 164 | |
| 15 | 2016 | 20 | |
| 16 | 2015 | 11 | |
| 17 | 2013 | 12 | |
| 18 | 2012 | 27 | |
| 19 | 2010 | 47 | |
| 20 | 2010 | 201 |
About Maarten A. Ligtenberg
Maarten A. Ligtenberg is a scholar working on Immunology, Oncology and Biotechnology, having authored 21 papers that have together received 964 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (11 papers), Cancer Immunotherapy and Biomarkers (11 papers), CAR-T cell therapy research (9 papers), Immune Cell Function and Interaction (5 papers), Cancer Cells and Metastasis (4 papers), Cancer Research and Treatments (3 papers), vaccines and immunoinformatics approaches (2 papers) and Phagocytosis and Immune Regulation (2 papers). The work is most often cited by research in Immunology (436 citations), Oncology (470 citations) and Infectious Diseases (145 citations). Maarten A. Ligtenberg has collaborated with scholars based in Netherlands, Sweden and United States. Frequent co-authors include Rolf Kiessling, Álvaro Lladser, Dimitrios Mougiakakos, Kristina Witt, Daniel S. Peeper, Tobias Riët, Markus Chmielewski, Madhura Mukhopadhyay, Hinrich Abken and Natalie A. Prow. Their work appears in journals such as Nature Medicine, Nature Communications and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.